Indeed, anti-SARS-CoV-2 antibodies produced in pediatric patients with multisystem inflammatory syndrome in children (MIS-C) have been shown to exhibit increased reactivity to a distinct domain of the N protein that shares remarkable structural similarity with the human antiviral response regulator SNX8, showing an example of molecular mimicry to avoid host defense by the virus [47]. The gene discussed is SNX8; the disease is COVID-19–associated multisystem inflammatory syndrome in children.